跳至主要内容
临床试验/NCT02899689
NCT02899689已完成不适用

Induction of Labor in Women With Unfavorable Cervix: Randomized Control Study Comparing Dilapan to Foley Bulb

The University of Texas Medical Branch, Galveston4 个研究点 分布在 1 个国家目标入组 419 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
419
试验地点
4
主要终点
Rate of Vaginal Delivery

研究概览

简要总结

Women undergoing mechanical cervical ripening for labor induction will be randomized to Dilapan-S® versus Foley bulb. The investigators hypothesized that osmotic cervical dilators (Dilapan-S®) are as effective as Foley bulb catheter in rates of vaginal delivery.

详细描述

Historically, mechanical methods were the first methods developed to ripen the cervix or to induce labor. Dilapan-S® a synthetic osmotic cervical dilator made of a patented hydrogel (AQUACRYL), works by stimulating the release of endogenous prostaglandins, which degrade collagen fibers and soften the cervix. Additionally, it dilates the cervix gradually and the effect is gentle as well as predictable. Recently, Dilapan-S® has been approved by the FDA as a mechanical dilator for cervical ripening. There are no data comparing this newly approved Dilapan-S® to the Foley catheter, the most commonly used mechanical dilator method. Therefore, The investigators propose a randomized controlled trial to determine the efficacy of Dilapan-S® compared with Foley catheter for cervical ripening before induction of labor in pregnant women greater than 37 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant woman scheduled for induction of labor.
  • Age between 18 and 45 years.
  • Understanding and capable to sign informed consent.
  • Singleton pregnancy.
  • Gestational age ≥ 37 0/7 weeks.
  • Live fetus in cephalic presentation.
  • Intact membranes.
  • Pelvic exam (sterile vaginal exam) of less than or equal to 3cm and at most 60% effaced.

排除标准

  • Iodine allergy.
  • Active labor or oxytocin has been administered.
  • Chorioamnionitis.
  • Prior uterine or cervical surgery.
  • Non reassuring fetal status requiring immediate delivery.
  • Non-cephalic fetal presentation.
  • Active vaginal bleeding from cervical os.
  • Placenta previa.
  • EFW > 5000 gm(non diabetic) or > 4500gm (diabetic).
  • Other contraindication to vaginal delivery.

结局指标

主要结局

Rate of Vaginal Delivery

时间窗: Through study completion, an average of 1-2 years

Proportion of patients that delivered vaginal. (%)

次要结局

  • Time to Reach Active Stage of Labor as ≥ 6cm Cervical Dilation(1-2 days)
  • Change in Bishop Scores(12-24 hrs)
  • Operative Deliveries(1-4 days)
  • Cesarean Deliveries(1-4 days)
  • Time of Vaginal Delivery(2-4 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验